SCM
Sio Capital Management Portfolio holdings
AUM
$249M
This Quarter Return
-7.2%
1 Year Return
+117.71%
3 Year Return
+238.99%
5 Year Return
+411.91%
10 Year Return
+912.87%
AUM
$310M
AUM Growth
+$310M
(-16%)
Cap. Flow
-$32.1M
Cap. Flow
% of AUM
-10.36%
Top 10 Holdings %
Top 10 Hldgs %
50.58%
Holding
85
New
10
Increased
22
Reduced
16
Closed
22
Top Buys
| 1 |
Galapagos
GLPG
|
$11.8M |
| 2 |
Cigna
CI
|
$10.2M |
| 3 |
Merck
MRK
|
$9.39M |
| 4 |
Cardinal Health
CAH
|
$5.32M |
| 5 |
RCOR
Renovacor, Inc.
RCOR
|
$4.85M |
Top Sells
| 1 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
$8.71M |
| 2 |
Amgen
AMGN
|
$8.53M |
| 3 |
AFMD
Affimed
AFMD
|
$6.07M |
| 4 |
Coherus Oncology, Inc. Common Stock
CHRS
|
$5.72M |
| 5 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
$5.6M |
Sector Composition
| 1 | Healthcare | 89.71% |
| 2 | Consumer Staples | 2.95% |
| 3 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Quince Therapeutics
QNCX
$86.5M
| – | – |
0
| – | – |
|
77
Seer Inc
SEER
$114M
| – | – |
-23,775
| Closed | -$779K |
|
78
Travere Therapeutics
TVTX
$1.75B
| – | – |
-150,000
| Closed | -$2.19M |
|
|
NARI
79
DELISTED
Inari Medical, Inc. Common Stock
NARI
| – | – |
-46,332
| Closed | -$4.32M |
|
|
BCEL
80
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| – | – |
-113,455
| Closed | -$967K |
|
|
SYNH
81
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| – | – |
-62,598
| Closed | -$5.6M |
|
|
EVLO
82
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| – | – |
0
| – | – |
|
|
HRC
83
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| – | – |
-76,647
| Closed | -$8.71M |
|
|
CHAQ.U
84
DELISTED
Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one
CHAQ.U
| – | – |
-400,000
| Closed | -$4.37M |
|
|
AHACU
85
DELISTED
Alpha Healthcare Acquisition Corp. Unit
AHACU
| – | – |
-100,000
| Closed | -$1.14M |
|